Literature DB >> 6733004

Saliva concentrations of isosorbide dinitrate, isosorbide 2-mononitrate and isosorbide 5-mononitrate.

I W Taylor, R M Major, L F Chasseaud, T Taylor.   

Abstract

Correlations between saliva and plasma concentrations of isosorbide dinitrate (ISDN), and its active metabolites, isosorbide 2-mononitrate (2-ISMN) and isosorbide 5-mononitrate (5-ISMN) were examined. In the case of 5-ISMN (r = 0.98, P less than 0.01), saliva concentrations are probably reliable indices of the plasma concentrations of this drug and their measurement should provide a useful non-invasive procedure to assess compliance during the clinical use of products containing either ISDN or 5-ISMN: it may also be helpful in assessing the clinical pharmacokinetics of 5-ISMN. Less satisfactory correlations were obtained for ISDN (r = 0.84) and 2-ISMN (r = 0.83).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6733004      PMCID: PMC1463459          DOI: 10.1111/j.1365-2125.1984.tb02394.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

Review 1.  Therapeutic drug monitoring in saliva.

Authors:  M Danhof; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1978 Jan-Feb       Impact factor: 6.447

2.  Use of saliva in therapeutic drug monitoring.

Authors:  M G Horning; L Brown; J Nowlin; K Lertratanangkoon; P Kellaway; T E Zion
Journal:  Clin Chem       Date:  1977-02       Impact factor: 8.327

Review 3.  Oral absorption and secretion of drugs.

Authors:  C F Speirs
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

4.  Biotransformation of isosorbide dinitrate in humans.

Authors:  W H Down; L F Chasseaud; R K Grundy
Journal:  J Pharm Sci       Date:  1974-07       Impact factor: 3.534

5.  Measurement of plasma concentrations of isosorbide dinitrate.

Authors:  E Doyle; L F Chasseaud; T Taylor
Journal:  Biopharm Drug Dispos       Date:  1980 Jan-Mar       Impact factor: 1.627

6.  Isosorbide 5-mononitrate pharmacokinetics in humans.

Authors:  T Taylor; L F Chasseaud; R Major; E Doyle; A Darragh
Journal:  Biopharm Drug Dispos       Date:  1981 Jul-Sep       Impact factor: 1.627

7.  Use of isosorbide dinitrate saliva concentrations for biopharmaceutical investigations.

Authors:  H Laufen; M Schmid; M Leitold
Journal:  J Pharm Sci       Date:  1983-05       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.